ArticleTargeted oncology2022

Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors.

Joan R E Choo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.